Kite Pharma to Present at June 2016 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq: KITE) today announced that management will present at two investor conferences in June:

Jefferies 2016 Healthcare Conference

• Date: Tuesday, June 7, 2016
• Time: 11:00 AM EDT
• Location: New York, NY

Goldman Sachs 37th Annual Healthcare Conference

• Date: Tuesday, June 7, 2016
• Time: 11:20 AM PDT
• Location: Palos Verdes, CA

A live audio webcast of both presentations will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of the webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160527005092/en/

Kite Pharma, Inc.
Greg Mann
VP, Investor Relations
[email protected]
or
For Media:
inVentiv Health
David Polk, 310-309-1029
[email protected]
or
Anne Cummings, 212-845-5632
[email protected]
or
Burns McClellan
Justin Jackson, 212-213-0006
[email protected]

Source: Kite Pharma, Inc.

You May Also Be Interested In

• Performance Medicine Institute Study Demonstrates Muscle Gains are Possible During GLP-1 Weight Loss
• Ecopetrol Completes Acquisition of a Controlling 51% Stake in Brava Energia S.A. and Strengthens Its Growth Platform in Brazil
• The Women’s Journal Highlights Rising Demand for Solo Travel Destinations